Articles

Potential Alzheimer’s drug further backs protein hypothesis

The results of an experimental drug for Alzheimer’s disease provide the best evidence so far that the memory-robbing condition is caused by an errant protein in the brain. Drugmakers including Eli Lilly have been concentrating their Alzheimer’s research on that area.

Read More

Lilly joins $100M global Alzheimer’s venture fund

Major drugmakers—including Indianapolis-based Eli Lilly and Co.—the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or cure.

Read More

Babies, business and the bottom line

For years, employers have focused on preventing huge health bills that can result from their older workers. But now Leonard Hoops, the CEO of Visit Indy, is trying to get employers to focus on the costs of the youngest members of their health plans: premature babies.

Read More